Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control.

IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Journal of Clinical and Translational Science Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI:10.1017/cts.2024.554
Robert Schnoll, Justin E Bekelman, Daniel Blumenthal, David A Asch, Alison M Buttenheim, Krisda H Chaiyachati, Susan M Domchek, Oluwadamilola M Fayanju, Peter Gabriel, Brian P Jenssen, Frank T Leone, Anne Marie McCarthy, Katherine L Nathanson, Ravi B Parikh, Katharine A Rendle, Rachel C Shelton, Lawrence N Shulman, Samuel U Takvorian, Susan Ware, E Paul Wileyto, Rinad S Beidas
{"title":"Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control.","authors":"Robert Schnoll, Justin E Bekelman, Daniel Blumenthal, David A Asch, Alison M Buttenheim, Krisda H Chaiyachati, Susan M Domchek, Oluwadamilola M Fayanju, Peter Gabriel, Brian P Jenssen, Frank T Leone, Anne Marie McCarthy, Katherine L Nathanson, Ravi B Parikh, Katharine A Rendle, Rachel C Shelton, Lawrence N Shulman, Samuel U Takvorian, Susan Ware, E Paul Wileyto, Rinad S Beidas","doi":"10.1017/cts.2024.554","DOIUrl":null,"url":null,"abstract":"<p><p>Traditional approaches for evaluating the impact of scientific research - mainly scholarship (i.e., publications, presentations) and grant funding - fail to capture the full extent of contributions that come from larger scientific initiatives. The Translational Science Benefits Model (TSBM) was developed to support more comprehensive evaluations of scientific endeavors, especially research designed to translate scientific discoveries into innovations in clinical or public health practice and policy-level changes. Here, we present the domains of the TSBM, including how it was expanded by researchers within the Implementation Science Centers in Cancer Control (ISC3) program supported by the National Cancer Institute. Next, we describe five studies supported by the Penn ISC3, each focused on testing implementation strategies informed by behavioral economics to reduce key practice gaps in the context of cancer care and identify how each study yields broader impacts consistent with TSBM domains. These indicators include <i>Capacity Building, Methods Development</i> (within the Implementation Field) and <i>Rapid Cycle Approaches</i>, implementing <i>Software Technologies</i>, and improving <i>Health Care Delivery</i> and <i>Health Care Accessibility</i>. The examples highlighted here can help guide other similar scientific initiatives to conceive and measure broader scientific impact to fully articulate the translation and effects of their work at the population level.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"8 1","pages":"e166"},"PeriodicalIF":2.1000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604509/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/cts.2024.554","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Traditional approaches for evaluating the impact of scientific research - mainly scholarship (i.e., publications, presentations) and grant funding - fail to capture the full extent of contributions that come from larger scientific initiatives. The Translational Science Benefits Model (TSBM) was developed to support more comprehensive evaluations of scientific endeavors, especially research designed to translate scientific discoveries into innovations in clinical or public health practice and policy-level changes. Here, we present the domains of the TSBM, including how it was expanded by researchers within the Implementation Science Centers in Cancer Control (ISC3) program supported by the National Cancer Institute. Next, we describe five studies supported by the Penn ISC3, each focused on testing implementation strategies informed by behavioral economics to reduce key practice gaps in the context of cancer care and identify how each study yields broader impacts consistent with TSBM domains. These indicators include Capacity Building, Methods Development (within the Implementation Field) and Rapid Cycle Approaches, implementing Software Technologies, and improving Health Care Delivery and Health Care Accessibility. The examples highlighted here can help guide other similar scientific initiatives to conceive and measure broader scientific impact to fully articulate the translation and effects of their work at the population level.

利用转化科学效益模型评估宾夕法尼亚大学实施科学中心在癌症控制方面的影响。
评估科学研究影响的传统方法——主要是奖学金(即出版物、演讲)和赠款资助——未能充分考虑到来自更大的科学倡议的贡献。开发转化科学效益模型(TSBM)是为了支持对科学努力进行更全面的评估,特别是那些旨在将科学发现转化为临床或公共卫生实践中的创新和政策层面变化的研究。在这里,我们介绍了TSBM的领域,包括由国家癌症研究所支持的癌症控制实施科学中心(ISC3)项目的研究人员如何扩展它。接下来,我们描述了宾夕法尼亚大学ISC3支持的五项研究,每项研究都侧重于测试由行为经济学提供的实施策略,以减少癌症治疗背景下的关键实践差距,并确定每项研究如何产生与TSBM领域一致的更广泛的影响。这些指标包括能力建设、方法开发(在实施领域内)和快速循环方法、实施软件技术以及改善卫生保健提供和卫生保健可及性。这里强调的例子可以帮助指导其他类似的科学举措,构思和衡量更广泛的科学影响,以充分阐明其工作在人口一级的转化和影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical and Translational Science
Journal of Clinical and Translational Science MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.80
自引率
26.90%
发文量
437
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信